CHE financials
Chemed (CHE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CHE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.53B | $758.34M | $338.25M | $265.24M | 18.42 |
| 2024 | $2.43B | $854.35M | $366.49M | $302.00M | 19.89 |
| 2023 | $2.26B | $798.82M | $340.57M | $272.51M | 17.93 |
| 2022 | $2.13B | $765.09M | $343.50M | $249.62M | 16.53 |
| 2021 | $2.14B | $769.80M | $343.04M | $268.55M | 16.85 |
| 2020 | $2.08B | $701.39M | $389.68M | $319.47M | 19.48 |
- CHE revenue was $2.53B in fiscal 2025, net income $265.24M.
Updated 2026-11-03 13:29 UTC